
Designs and flies small autonomous capsules that manufacture pharmaceuticals in microgravity and return them to Earth by reentry, exploiting how zero-g improves drug crystallisation. Founded by ex-SpaceX engineer Will Bruey and Founders Fund's Delian Asparouhov, it is the best-funded firm in in-space manufacturing; its W-series capsules have flown and recovered active-ingredient payloads, and it also markets its reentry vehicles for hypersonic testing.
Private company — financial figures are public estimates. Privately held; reached unicorn status at its $187M Series C (July 2025); ~$329M raised in total.